Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06075316 · ClinicalTrials.gov registry record · NA

Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

A NA study of Thoracic, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06075316: Recruiting NA study of Thoracic, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06075316 is a NA study of Thoracic that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 200 participants, above the 108-participant average among 5 other Thoracic trials with a reported enrollment target (85% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06075316, a NA study of Thoracic, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This is a single-site, non-randomized study on the outcomes of remote real-time "ePRO monitoring" in thoracic surgery patients. ePRO monitoring is a health information technology intervention comprised of delivering longitudinal electronic patient-reported outcome (ePRO) surveys (e.g., on symptoms, and physical functioning) coupled with automated provider alerts for concerning survey responses.

Primary Outcome

Percentage of eligible thoracic surgery patients enrolling in ePRO monitoring.

Conditions Studied

Interventions

  • OTHER Symptom monitoring

Study Locations (1)

North Carolina

  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-11-14
Est. Completion 2026-12-31
Phase NA

What NCT06075316 shows while recruiting

NCT06075316 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 108-participant average among 5 other Thoracic trials with a reported enrollment target (85% higher).

The record links to 1 condition, with Thoracic appearing as the primary indexed condition, and to 1 intervention - of which Symptom monitoring is the first listed.

NCT06075316 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06075316 about?

NCT06075316 is a clinical study titled "Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)". This is a single-site, non-randomized study on the outcomes of remote real-time "ePRO monitoring" in thoracic surgery patients. ePRO monitoring is a health information technology intervention comprised of delivering longitudinal electronic patient-reported outcome (ePRO) surveys (e.g., on symptoms, ...

What is the current status of trial NCT06075316?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-14. Estimated completion is 2026-12-31.

What conditions does trial NCT06075316 study?

This clinical trial studies the following conditions: Thoracic.

What interventions are being tested in trial NCT06075316?

The interventions under investigation include: Symptom monitoring (OTHER).

Who is sponsoring clinical trial NCT06075316?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06075316 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06075316, the US trial registry maintained by the National Library of Medicine. NCT06075316 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.